Trial Profile
Efficacy of direct-acting antiviral treatment with simeprevir, daclatasvir, sofosbuvir in treatment naive patients with Hepatiis C infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2017
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 10 Feb 2017 New trial record